Search details
1.
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
N Engl J Med
; 390(12): 1080-1091, 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38507751
2.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Article
in English
| MEDLINE | ID: mdl-34081848
3.
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Future Oncol
; 20(8): 423-436, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37387213
4.
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial.
Breast Cancer Res Treat
; 191(3): 565-576, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34860318
5.
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Lancet Oncol
; 22(1): 85-97, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33357420
6.
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol
; 22(2): 212-222, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33460574
7.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Lancet
; 396(10265): 1817-1828, 2020 12 05.
Article
in English
| MEDLINE | ID: mdl-33278935
8.
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study.
Breast Cancer Res Treat
; 187(2): 467-476, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33748921
9.
The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
World J Surg Oncol
; 13: 299, 2015 Oct 13.
Article
in English
| MEDLINE | ID: mdl-26462471
10.
Retrospective Observational Study to Determine the Epidemiology and Treatment Patterns of Patients with Triple-Negative Breast Cancer.
Cancers (Basel)
; 16(6)2024 Mar 07.
Article
in English
| MEDLINE | ID: mdl-38539422
11.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
J Clin Oncol
; : JCO2301500, 2024 Mar 27.
Article
in English
| MEDLINE | ID: mdl-38537155
12.
Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study.
Cancers (Basel)
; 15(22)2023 Nov 16.
Article
in English
| MEDLINE | ID: mdl-38001709
13.
Immediate breast reconstruction in breast cancer patients with the use of Serasynth and SeragynBR synthetic meshes. Single-oncological center experience, analysis of complications.
Pol Przegl Chir
; 96(2): 11-20, 2023 Oct 12.
Article
in English
| MEDLINE | ID: mdl-38629281
14.
Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study.
PLoS One
; 18(8): e0288146, 2023.
Article
in English
| MEDLINE | ID: mdl-37590267
15.
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.
BMC Cancer
; 12: 107, 2012 Mar 22.
Article
in English
| MEDLINE | ID: mdl-22439647
16.
Neoadjuvant Pertuzumab Plus Trastuzumab in Combination with Docetaxel and Carboplatin in Patients with HER2-Positive Breast Cancer: Real-World Data from the National Institute of Oncology in Poland.
Cancers (Basel)
; 14(5)2022 Feb 26.
Article
in English
| MEDLINE | ID: mdl-35267525
17.
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.
J Clin Oncol
; 40(5): 438-448, 2022 02 10.
Article
in English
| MEDLINE | ID: mdl-34890214
18.
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
J Clin Oncol
; 40(3): 282-293, 2022 01 20.
Article
in English
| MEDLINE | ID: mdl-34874182
19.
Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
Ann Surg Oncol
; 17(12): 3314-23, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-20607422
20.
Melanoma without a detectable primary site with metastases to lymph nodes.
Dermatol Surg
; 36(6): 868-76, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20482725